Andaleb Kholmukhamedov/LinkedIn
Oct 4, 2025, 12:38
Andaleb Kholmukhamedov: Anticoagulation Management: Current Landscape And Future Trends
Andaleb Kholmukhamedov, Head of Hemostasis Assay Development at Werfen North America, posted on LinkedIn:
”Latest publication in the MDPI Journal of Clinical Medicine’s Special Issue on Advances in Thrombosis and Haemostasis
Our paper provides a comprehensive review of the current and future landscape of Anticoagulation Therapy – a critical field balancing life-saving clot prevention with bleeding risk.”
Read the full article here.
Title: Anticoagulation Management: Current Landscape and Future Trends
Authors: Andaleb Kholmukhamedov, David Subbotin, Anna Gorin, Ruslan Ilyassov
Stay updated with Hemostasis Today.
Andaleb Kholmukhamedov
Anna Gorin
Anticoagulation
Anticoagulation Management
Anticoagulation Therapy
Bleeding Risk
Blood Clot
David Subbotin
Health
Hematology
Hemostais
Hemostais Today
MDPI Journal
Medicine
Ruslan Ilyassov
San Diego State University
Scripps Memorial Hospital
thrombosis
University of California Los Angeles
Versiti Blood Research Institute
Werfen North America
-
Apr 11, 2026, 13:51David McIntosh: Vital Plasma Derived Medicines – The Anomalous UK Scene
-
Apr 11, 2026, 13:47Samrawit Terefe: O Negative Blood Is the Universal Donor With Extreme Scarcity
-
Apr 11, 2026, 13:39Dheeraj Garg: Rethinking Cardiovascular Disease – A Cardiologist’s Perspective
-
Apr 11, 2026, 13:37Kushal Bhatia: Is The 4.5-Hour Thrombolysis Window Officially Outdated?
-
Apr 11, 2026, 13:35William Aird: Why Did Mammalian Red Blood Cells Give Up Their Nucleus?
-
Apr 11, 2026, 13:30Ken Kuang: Gravity Is Constant, But Your Vein Health Doesn’t Have to Be
-
Apr 11, 2026, 13:21Mascha Kern: Measuring Gender’s Role in Stroke and Migraine
-
Apr 11, 2026, 13:10Danique Steeghs: Key Findings from a Microfluidic Chemiluminescent Thrombin Generation Assay
-
Apr 11, 2026, 13:06Shanvi Mahi: A Validated Tool to Explore Lived Experiences After Stroke Rehabilitation